EMBL-EBI | Chemical Biology | ChEBI

Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search

CHEBI:135938 - lasofoxifene

Default Structure
ChEBI IDCHEBI:135938
ChEBI Namelasofoxifene
Stars
DefinitionA member of the class of tetralins that is 5,6,7,8-tetrahydronaphthalen-2-ol in which the hydrogens at positions 5 and 6 are replaced by 4-[2-(pyrrolidin-1-yl)ethoxy]phenyl and phenyl groups, respectively (the 5R,6S-stereoisomer). It is a selective estrogen receptor modulator indicated for the prevention and treatment of osteoporosis in post-menopausal women.
Secondary ChEBI IDCHEBI:41282
Last Modified29 September 2020
DownloadsMolfile
FormulaC28H31NO2
Net Charge0
Average Mass413.561
Monoisotopic Mass413.23548
SMILES[H][C@@]1(c2ccc(OCCN3CCCC3)cc2)c2ccc(O)cc2CC[C@]1([H])c1ccccc1
InChIInChI=1S/C28H31NO2/c30-24-11-15-27-23(20-24)10-14-26(21-6-2-1-3-7-21)28(27)22-8-12-25(13-9-22)31-19-18-29-16-4-5-17-29/h1-3,6-9,11-13,15,20,26,28,30H,4-5,10,14,16-19H2/t26-,28+/m1/s1
InChIKeyGXESHMAMLJKROZ-IAPPQJPRSA-N
Wikipedia
Roles Classification
Chemical Role:
Bronsted base  A molecular entity capable of accepting a hydron from a donor (Brønsted acid).
Biological Roles:
estrogen receptor antagonist  An antagonist at the estrogen receptor.
estrogen receptor agonist  An agonist at the estrogen receptor.
Applications:
estrogen receptor antagonist  An antagonist at the estrogen receptor.
cardioprotective agent  Any protective agent that is able to prevent damage to the heart.
antineoplastic agent  A substance that inhibits or prevents the proliferation of neoplasms.
bone density conservation agent  An agent that inhibits bone resorption and/or favor bone mineralization and bone regeneration. Used to heal bone fractures and to treat bone diseases such as osteopenia and osteoporosis.
ChEBI Ontology
Outgoing Relation(s)
lasofoxifene (CHEBI:135938) has role antineoplastic agent (CHEBI:35610)
lasofoxifene (CHEBI:135938) has role bone density conservation agent (CHEBI:50646)
lasofoxifene (CHEBI:135938) has role cardioprotective agent (CHEBI:77307)
lasofoxifene (CHEBI:135938) has role estrogen receptor agonist (CHEBI:63951)
lasofoxifene (CHEBI:135938) has role estrogen receptor antagonist (CHEBI:50792)
lasofoxifene (CHEBI:135938) is a N-alkylpyrrolidine (CHEBI:46775)
lasofoxifene (CHEBI:135938) is a aromatic ether (CHEBI:35618)
lasofoxifene (CHEBI:135938) is a naphthols (CHEBI:25392)
lasofoxifene (CHEBI:135938) is a tetralins (CHEBI:36786)
IUPAC Name 
(5R,6S)-6-phenyl-5-{4-[2-(pyrrolidin-1-yl)ethoxy]phenyl}-5,6,7,8-tetrahydronaphthalen-2-ol
INNs  Source
lasofoxifeneWHO MedNet
lasofoxiféneWHO MedNet
lasofoxifenoWHO MedNet
lasofoxifenumWHO MedNet
Synonyms  Source
CP 336156ChemIDplus
CP-336,156ChemIDplus
CP-336156DrugCentral
(−)-cis-5,6,7,8-tetrahydro-6-phenyl-5-(p-(2-(1-pyrrolidinyl)ethoxy)phenyl)-2-naphtholChemIDplus
(−)-cis-(5R,6S)-6-phenyl-5-[4-(2-pyrrolidin-1-ylethoxy)phenyl]-5,6,7,8-tetrahydronaphthalen-2-olChEBI
Brand Name  Source
OporiaChemIDplus
Manual XrefsDatabases
4308DrugCentral
C3DPDBeChem
DB06202DrugBank
LasofoxifeneWikipedia
Registry NumbersSources
CAS:180916-16-9ChemIDplus
Citations